Cell Lines Blog

An online resource for navigating the complexities of cell sourcing, supply chain and clinical development.

View all Allogeneic Cell Sourcing Featured Industry Standardization Industry Updates Outcomes Reporting Supply Chain

4 benefits of cord blood for allogeneic cell therapies

Read more

HLA, histocompatibility and the science of cell source selection

Read more

Behind the scenes of a cell therapy transport

Read more

The value of cord blood as an allogeneic source material

Read more

Effect of rapid cell therapy growth on collection capacity

Read more

A defining year for advancements in cell and gene therapy

Read more

The promise allogeneic NK cell and iPSC therapies hold

Read more

Cell and gene therapy logistics blog header image

Which cell therapy supply chain changes are here to stay?

Read more

Creating scalable cell therapy collection processes

Read more

Strategies for successful commercial-readiness in gene therapy

Read more

Another record year for cell and gene therapies?

Read more

Martin Maiers is the Vice President of Innovation at the NMDP/Be The Match

HLA’s future impact on allogeneic cell therapy development

Read more

Load more